NCT00302861View on ClinicalTrials.gov

A Study to Evaluate the Treatment of Previously Untreated B-Cell Chronic Lymphocytic Leukemia (B-CLL)

PHASE1/PHASE2TerminatedINTERVENTIONAL
Enrollment

86

Participants

Timeline

Start Date

March 31, 2006

Conditions
B-Cell Chronic Lymphocytic Leukemia
Interventions
BIOLOGICAL

MyVax

Sponsors
All Listed Sponsors
lead

Genitope Corporation

INDUSTRY

NCT00302861 - A Study to Evaluate the Treatment of Previously Untreated B-Cell Chronic Lymphocytic Leukemia (B-CLL) | Biotech Hunter | Biotech Hunter